Skip to main content
Premium Trial:

Request an Annual Quote

Benitec Says European Patent Forthcoming on HCV Inhibition Technology

Premium

Benitec said this week that it has received a notice that the European Patent Office will issue a patent on a company application covering the use of an RNA construct to inhibit hepatitis C virus levels in cells, tissues, and organs.

The application, No. 2005727680, is entitled, "Multiple Promoter-Expression Cassettes for Simultaneous Delivery of RNAi Agents." The rights to the intellectual property were previously licensed to Tacere Therapeutics (GSN 10/12/2006), which is developing an shRNA-based HCV therapy with Pfizer.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.